前收市價 | 10.10 |
開市 | 11.50 |
買盤 | 9.40 |
賣出價 | 12.00 |
拍板 | 30.00 |
到期日 | 2024-06-21 |
今日波幅 | 9.60 - 11.50 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 2.32k |
Initial data from an early-stage study shows that treatment with Avidity's (RNA) experimental therapy could address the underlying cause of a rare muscle-weakening condition.
Avidity unveiled "impressive" results from a study of its treatment for a rare form of muscular dystrophy. The top biotech stock soared.
These two biotechnology stocks could be gearing up for a run.